Jpmorgan Chase & CO Outset Medical, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Outset Medical, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 15,895 shares of OM stock, worth $14,464. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,895
Previous 3,073,669
99.48%
Holding current value
$14,464
Previous $11.8 Million
99.92%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding OM
# of Institutions
91Shares Held
19.9MCall Options Held
66.8KPut Options Held
60.3K-
Vanguard Group Inc Valley Forge, PA2.64MShares$2.41 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.89MShares$1.72 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.81MShares$1.65 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA1.47MShares$1.34 Million0.04% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.39MShares$1.26 Million0.0% of portfolio
About Outset Medical, Inc.
- Ticker OM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 48,007,300
- Market Cap $43.7M
- Description
- Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...